We're starting off 2018 strong with three new publications in the Delgoffe Lab!
Check out a new review by Dayana and Greg in Clinical Cancer Research: Antitumor T cell reconditioning: improving metabolic fitness for optimal cancer immunotherapy.
It was a long time coming, but Menk & Scharping et al published in Cell Reports: Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions.
And the newest pub (which came out today!) by Menk et al in the Journal of Experimental Medicine: 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses.
Go check out our new research, and congrats to all the lab members involved!